- Guillaume Pfefer, Ph.D., MBA to serve as CEO; John Mendlein, Ph.D. to serve as Executive Chairman Sail unites Laronde and Senda Biosciences, two companies that deliver more than eight years of ...
Not only can these particles be transformed into tooth-cleaning shapes, but their action can have antimicrobial effects that destroy plaque-causing bacteria. Share on Facebook (opens in a new window) ...
SOMERVILLE, Mass.--(BUSINESS WIRE)--Sail Biomedicines, Inc. (“Sail”), a Flagship Pioneering company and leader in RNA-based programmable medicines, today announced that Kerry Benenato, Ph.D., has been ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sail Biomedicines, Inc. (“Sail”), a Flagship Pioneering company and leader in RNA-based programmable medicines, today announced that Laura Sepp-Lorenzino, Ph.D., has ...
TEL AVIV, Israel, Oct. 10, 2023 /PRNewswire/ -- Mana.bio, a biotechnology company accelerating programmable drug delivery, today unveiled its AI-based lipid nanoparticle (LNP) delivery platform to ...
The Nature Index 2025 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...
Case Western Reserve University chemist Divita Mathur was awarded a National Science Foundation (NSF) Faculty Early Career Development Program (CAREER) grant for her research in synthetic DNA ...
CLEVELAND—Case Western Reserve University chemist Divita Mathur was awarded a National Science Foundation (NSF) Faculty Early Career Development Program (CAREER) grant for her research in synthetic ...
CAMBRIDGE, Mass., Oct. 19, 2023 /PRNewswire/ -- Flagship Pioneering today announced the combination of Laronde and Senda Biosciences to launch Sail Biomedicines, a company pioneering the design and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback